Manganese-enhanced MRI of human choroidal melanoma xenografts

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 3, 2007, Pages 963-967

  Braun, Rod D ^a,b   Gradianu, Marias ^a   Vistisen, Kerry S ^a   Roberts, Robin L ^a   Berkowitz, Bruce A ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; MANGANESE CHLORIDE; CHLORIDE; DIAGNOSTIC AGENT; MANGANESE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CHOROID MELANOMA; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETINA; SPHEROID CELL; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; CHOROID; CHOROID TUMOR; DISEASE MODEL; MELANOMA; METHODOLOGY; MULTICELLULAR SPHEROID; NUDE RAT; PATHOLOGY; RAT; RAT STRAIN; XENOGRAFT;

ANIMALS; CHLORIDES; CHOROID; CHOROID NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; MANGANESE COMPOUNDS; MELANOMA; NEOPLASM TRANSPLANTATION; RATS; RATS, MUTANT STRAINS; RATS, NUDE; RETINA; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 34047271454     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1156     Document Type: Article

References (30)

1. Sahel JA, Albert DM. Intraocular melanomas. Cancer Treat Res. 1993;65:161-199.
2. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, Ill: initial mortality findings. COMS Report No. 18. Arch Ophthalmol. 2001;119:969-982.
3. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol. 1997;42:215-232.
4. COMS. Collaborative ocular melanoma study (COMS) randomized trial of 1-125 brachytherapy for medium choroidal melanoma: 1. visual acuity after 3 years COMS report no. 16. Ophthalmology. 2001;108:348-366.
5. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol. 2000;118:1219-1228.
6. Gragoudas ES, Lane AM, Regan S, et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000;118:773-778.
7. Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology. 1999;106:1571-1578.
8. Gragoudas ES, Egan KM, Walsh SM, Regan S, Munzenrider JE, Taratuta V. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol. 1995;119:157-164.
9. Berkowitz BA, Roberts R, Goebel DJ, Luan H. Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI. Invest Ophthalmol Vis Sci. 2006;47:2668-2674.
10. 1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med. 1997;38:378-388.
11. Yu X, Wadghiri YZ, Sanes DH, Turnbull DH. In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat Neurosci. 2005;8:961-968.
12. Tamano H, Enomoto S, Oku N, Takeda A. Preferential uptake of zinc, manganese, and rubidium in rat brain tumor. Nucl Med Biol. 2002;29:505-508.
13. Braun RD, Abbas A. Orthotopic human choroidal melanoma xenografts in nude rats with aggressive and nonaggressive PAS staining patterns. Invest Ophthalmol Vis Sci. 2006;47:7-16.
14. Daniels KJ, Boldt HC, Martin JA, Gardner LM, Meyer M, Folberg R. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression. Lab Invest. 1996;75:55-66.
15. Yuhas JM, Li AP, Martinez AO, Ladman AJ. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 1977;37:3639-3643.
16. 2 predicts therapeutic efficacy in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci. 2001;42:2964-2969.
17. Schupp DG, Merkle H, Ellermann JM, Ke Y, Garwood M. Localized detection of glioma glycolysis using edited 1H MRS. Magn Reson Med. 1993;30:18-27.
18. Berkowitz BA, Kowluru RA, Frank RN, Kern TS, Hohman TC, Prakash M. Subnormal retinal oxygenation response precedes diabetic-like retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2100-2105.
19. 1 agent manganese chloride. NMR Biomed. 2006;19:50-59.
20. Gimi B, Leoni L, Oberholzer J, et al. Functional MR microimaging of pancreatic beta-cell activation. Cell Transplant. 2006;15:195-203.
21. Peyster RG, Augsburger JJ, Shields JA, Hershey BL, Eagle R Jr. Haskin ME. Intraocular tumors: evaluation with MR imaging. Radiology. 1988;168:773-779.
22. 2+ oscillations in glucose-stimulated pancreatic beta-cells. Am J Physiol. 1999;276:E512-518.
23. Crossgrove JS, Yokel RA. Manganese distribution across the blood-brain barrier. IV. Evidence for brain influx through store-operated calcium channels. Neurotoxicology. 2005;26:297-307.
24. 2+ signaling and control of growth and proliferation. Biol Cell. 2004;96:55-68.
25. Munaron L, Antoniotti S, Lovisolo D. Intracellular calcium signals and control of cell proliferation: how many mechanisms? J Cell Mol Med. 2004;8:161-168.
26. Kohn EC, Alessandro R, Spoonster J, Wersto RP, Liotta LA. Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci USA. 1995;92:1307-1311.
27. Adam G, Brab M, Bohndorf K, Gunther RW. Gadolinium-DTPA-enhanced MRI of intraocular tumors. Magn Reson Imaging. 1990;8:683-689.
28. Berkowitz BA, McDonald C, Ito Y, Tofts PS, Latif Z, Gross J. Measuring the human retinal oxygenation response to a hyperoxic challenge using MRI: eliminating blinking artifacts and demonstrating proof of concept. Magn Reson Med. 2001;46:412-416.
29. Trick GL, Edwards P, Desai U, Berkowitz BA. Early supernormal retinal oxygenation response in patients with diabetes. Invest Ophthalmol Vis Sci. 2006;47:1612-1619.
30. Trick GL, Liggett J, Levy J, et al. Dynamic contrast enhanced MRI in patients with diabetic macular edema: initial results. Exp Eye Res. 2005;81:97-102.